The 47th Annual Meeting of the Japanese Society for Immunology

Dates: 10-12 December, 2018 Venue: Fukuoka International Congress Center President: Kazuhiko Yamamoto (RIKEN)

Best Presentation Award Winner 2018

JSI gives an award to the superior presenters in the workshop and poster session of the JSI Annual Meeting.
Two awardees are selected in an each category by workshop coordinators and chairpersons.
This award is supported by BioLegend, Tomy Digital Biology and Sanofi.

1. Hematopoiesis and Immune Environment

Program NoNameTitle
1-C-WS3-13-O/PYuichi Hirata (Columbia Univ.)CD150high Bone Marrow Tregs Maintain Hematopoietic Stem Cell Quiescence and Immune Privilege via Adenosine
1-C-WS4-3-O/PMasanori Tsutsumi (The Univ. of Tokyo)Characterization of thymic fibroblast subsets

2. B cells

Program NoNameTitle
1-D-WS5-10-O/PKei Haniuda (Tokyo Univ. of Science)Metabolic control of germinal center B cell and plasma cell differentiation
1-D-WS6-4-O/PYoshihito Nihei (Juntendo Univ.)Characteristics of naïve B cells in murine IgA Nephropathy

3. T cells

Program NoNameTitle
2-A-WS14-4-O/PYuji Kamioka (Kansai Medical Univ.)Roles of Rap1, Talin-1 and Kindlin-3 in lymphocyte homing to peripheral and mucosal lymph nodes
3-A-WS23-14-O/PMoe Shiokawa (Osaka Univ.)Low-affinity TCR engagement induces Itm2a to mediate T cell maintenance in the periphery

4. Helper T cells

Program NoNameTitle
1-H-WS13-4-O/PMasayuki Tsukasaki (The Univ. of Tokyo)Host defense against oral bacteria by bone-damaging T cells
1-H-WS13-15-O/PHayato Takahashi (Keio Univ.)Cholesterol 25-hydroxylase expressing CD4+ T cell regulates tissue inflammation

5. Innate lymphocytes

Program NoNameTitle
1-B-WS1-5-O/PSaya Moriyama (Cornell Univ.)β2 adrenergic receptor-mediated negative regulation of group 2 innate lymphoid cell responses
1-B-WS2-8-O/PAsako Chiba (Juntendo Univ.)MAIT cells as a new therapeutic target for systemic lupus erythematosus.

6. Dendritic cells and macrophages

Program NoNameTitle
1-E-WS8-3-O/PEtsuko Toda (Tokyo Univ. of Science)A chemokine signal amplifier FROUNT promotes tumor progression by facilitating migration and activation of tumor-associated macrophage
1-E-WS7-5-O/PNaoko Shibata (Waseda Univ.)LPS from lymphoid-tissue resident Alcaligenes induces IgA without excessive inflammation via its weak TLR4 agonist activity.

7. Mast cells & granulocytes

Program NoNameTitle
2-H-WS21-1-O/PYaqiu Wang (Univ. of Tsukuba)Phosphatidylserine exposure self-regulates mast cells’ degranulation
2-H-WS21-6-O/PSoichiro Yoshikawa (Tokyo medical and dental Univ. (TMDU))Histamine released from skin-infiltrating basophils but not mast cells is crucial for acquired tick resistance in mice

8. Allergy

Program NoNameTitle
2-G-WS20-7-O/PMiyuki Omori-Miyake (Tokyo Women’s Medical Univ.)Identification and functional analyses of three dendritic cell subsets accumulating in skin-draining lymph nodes upon the expression of thymic stromal lymphopoiein in the skin
2-G-WS20-8-O/PAkihiko Murata (Tottori Univ.)Local skin memory response is mediated by tissue resident memory T cells

9. Cytokines and chemokines

Program NoNameTitle
1-G-WS11-16-O/PRuka Setoguchi (RIKEN)Chronic interferon-gamma signals impair memory CD8 T cell maintenance
1-G-WS12-3-O/PTomohiko Okazaki (The Univ. of Tokyo)A division of labour for the type ?interferon and apoptosis induction after viral infection

10. Tolerance and Immune suppression

Program NoNameTitle
2-C-WS16-13-O/PShin-ichi Koizumi (Okinawa Institute of Science and Technology Graduate Univ.)Transcription factor JunB is essential for effector regulatory T cell homeostasis and function
3-C-WS27-2-O/PTetsuya Sakurai (Kyushu Univ.)A novel mechanism for induction of tissue-specific immune evasion

11. Virus infection

Program NoNameTitle
2-B-WS15-7-O/PHiroshi Ueki (Univ. of Tokyo)In vivo imaging of the pathophysiological changes and dynamics of immune cells in influenza virus-infected mouse lung
2-B-WS15-19-O/PRyota Sato (The Univ. of Tokyo)Combating herpesvirus encephalitis by potentiating a TLR3-mTORC2 axis

12. Bacterial / mycofungal / parasite infection

Program NoNameTitle
3-H-WS36-1-O/PYasunobu Miyake (Saga Univ.)Porphyromonas gingivalis negatively regulates host immune responses through inhibitory receptor, Siglec
3-H-WS36-17-O/PHiroshi Ashida (Tokyo Medical and Dental Univ.)Analysis of novel Shigella effector mechanism that regulate host cell death

13. Endogeneous innate immunity and inflammation

Program NoNameTitle
3-D-WS28-12-O/PKaiwen Liu (The Univ. of Tokyo)Ribonuclease T2 negatively regulates response of the dsRNA sensor TLR3
3-D-WS29-8-O/PChihiro Motozono (Osaka Univ.)Recognition of phospholipids on dead cells via inhibitory C-type lectin receptor

14. Mucosal-Skin Immunity

Program NoNameTitle
3-F-WS33-5-O/PTakeshi Tanoue (Keio Univ. School of Medicine)Induction of IFNγ-producing CD8 T cells by human derived-commensal bacteria
3-F-WS33-4-O/PTadashi Takeuchi (RIKEN)Gut microbial metabolite acetate tunes IgA reactivity toward commensal microbes to maintain mucosal homeostasis

15. Tissue-specific immune diseases

Program NoNameTitle
3-B-WS24-7-O/PXuexin Li (Tokyo Medical and Dental Univ.)Significant associations of human SIGLEC10 polymorphisms with susceptibility to Guillain-Barré syndrome
3-B-WS24-10-O/PHui Jin (Osaka Univ.)TSHR-stimulating autoantibody production by TSHR / MHC class II complexes

16. Systemic autoimmune diseases

Program NoNameTitle
1-F-WS9-1-O/PYusuke Takeshima (The Univ. of Tokyo)Immune cell-type specific multi-omics analysis revealed contribution of mitochondria in Bcells to systemic lupus erythematosus.
1-F-WS10-5-O/PHaruka Tsuchiya (The Univ. of Tokyo)The Immunogenetics of Inflammatory Mechanisms by Fibroblast-like Synoviocytes form Rheumatoid Arthritis Patients

17. Tumor immunity

Program NoNameTitle
3-G-WS34-4-O/PMariko Takahashi (La Jolla Institute for Allergy and Immunology)Tumor suppressors of the DAPK family regulate anti-tumor innate immunity through the STING-type I Interferon pathway
3-G-WS35-14-O/PYujiro Kidani (Osaka Univ.)Distinct transcriptional regulation in tumor-infiltrating regulatory T cells

18. Cancer immunotherapy

Program NoNameTitle
3-E-WS30-1-O/PHirotake Tsukamoto (Kumamoto Univ.)Combined blockade of IL-6 and PD-1/PD-L1 signaling abrogates mutual regulation of their immunosuppressive effects in the tumor microenvironment
3-E-WS31-6-O/PHsin-Wei Chen (National Health Research Institutes)Use of FLIPr as an antigen delivery vector for cancer immunotherapy

19. Human Immunology (Immunointervention)

Program NoNameTitle
3-H-WS37-5-O/PYuki Hitomi (The Univ. of Tokyo)Identification of POGLUT1 as the effector gene in human primary biliary cholangitis (PBC) susceptibility locus chromosome 3q13.33
3-H-WS37-22-O/PMasashi Matsuda (RIKEN)Human NK cell development in hIL-7 and hIL-15 knock-in NOD/SCID/IL2rgKO mice

page top